Intermittent fasting for the prevention of cardiovascular disease: implications for clinical practice

Oliver Hamer,Abdulrahman Abouzaid,James Hill

DOI: https://doi.org/10.12968/bjca.2023.0058

2023-09-02

British Journal of Cardiac Nursing

Abstract:In this commentary, Oliver Hamer and colleagues critically appraise a Cochrane systematic review that synthesised the potential benefits of intermittent fasting for the prevention of cardiovascular disease.

What problem does this paper attempt to address?

Intermittent fasting and cardiovascular disease: A scoping review of the evidence

Sneha Annie Sebastian,Yash Shah,Camelia Arsene

DOI: https://doi.org/10.1016/j.disamonth.2024.101778

IF: 4.477

2024-06-24

Disease-a-Month

Abstract:Intermittent fasting (IF), characterized by alternating periods of fasting and unrestricted eating, typically within an 8-hour window or less each day, has gained significant attention as a possible dietary approach. While it is recognized for its metabolic advantages, like weight loss and enhanced glucose and insulin sensitivity, its effect on cardiovascular health remains a topic of mixed opinions. Recent findings suggest a potential downside, with reports indicating a concerning association: a 91 % higher risk of cardiovascular disease (CVD) mortality compared to eating spread across a 12- to 16-hour period. Despite this alarming statistic, the evidence cannot establish a causal link. The impact of IF on CVD is still insufficiently understood, with benefits sometimes exaggerated and risks downplayed in popular discourse. This scoping review aims to consolidate the current evidence, addressing unresolved questions about the benefits and risks of IF, particularly its association with CVD risks and mortality. The goal is to provide a balanced perspective on the potential health implications of IF, emphasizing the need for further research to clarify its long-term effects on cardiovascular health.

medicine, general & internal
Intermittent Fasting Regulates Metabolic Homeostasis and Improves Cardiovascular Health

DOI: https://doi.org/10.1007/s12013-024-01314-9

2024-06-08

Cell Biochemistry and Biophysics

Abstract:Obesity is a leading cause of morbidity and mortality globally. While the prevalence of obesity has been increasing, the incidence of its related complications including dyslipidemia and cardiovascular disease (CVD) has also been rising. Recent research has focused on modalities aimed at reducing obesity. Several modalities have been suggested including behavioral and dietary changes, medications, and bariatric surgery. These modalities differ in their effectiveness and invasiveness, with dietary changes gaining more interest due to their minimal risks compared to other modalities. Specifically, intermittent fasting (IF) has been gaining interest in the past decade. IF is characterized by cycles of alternating fasting and eating windows, with several different forms practiced. IF has been shown to reduce weight and alleviate obesity-related complications. Our review of clinical and experimental studies explores the effects of IF on the lipid profile, white adipose tissue (WAT) dynamics, and the gut microbiome. Notably, IF corrects dyslipidemia, reduces WAT accumulation, and decreases inflammation, which reduces CVD and obesity. This comprehensive analysis details the protective metabolic role of IF, advocating for its integration into public health practices.

biochemistry & molecular biology,cell biology,biophysics
Risks and benefits of intermittent fasting for the aging cardiovascular system

Mualla Ozcan,Mahmoud Abdellatif,Ali Javaheri,Simon Sedej

DOI: https://doi.org/10.1016/j.cjca.2024.02.004

IF: 6.614

2024-02-01

Canadian Journal of Cardiology

Abstract:Population aging and the associated increase in cardiovascular disease rates pose serious threats to global public health. Different forms of fasting have become an increasingly attractive strategy to directly address aging and potentially limit or delay the onset of cardiovascular diseases. A growing number of experimental studies and clinical trials indicate that the amount and timing of food intake as well as the daily time window during which food is consumed, are crucial determinants of cardiovascular health. Indeed, intermittent fasting counteracts the molecular hallmarks of cardiovascular aging and promotes different aspects of cardiometabolic health, including blood pressure and glycemic control, as well as body weight reduction. Here, we summarize current evidence from randomized clinical trials of intermittent fasting on body weight and composition as well as cardiovascular and metabolic risk factors. Moreover, we critically discuss the preventive and therapeutic potential of intermittent fasting, but also possible detrimental effects in the context of cardiovascular aging and related disease. We delve into the physiological mechanisms through which intermittent fasting might improve cardiovascular health, and raise important factors to consider in the design of clinical trials examining the efficacy of intermittent fasting to reduce major adverse cardiovascular events among aged individuals at high risk of cardiovascular disease. We conclude that despite growing evidence and interest among both the lay and scientific communities in the cardiovascular health-improving effects of intermittent fasting, further research efforts and appropriate caution are warranted before broadly implementing intermittent fasting regimens, especially in the elderly.

cardiac & cardiovascular systems
Intermittent Fasting: The Choice for a Healthier Lifestyle

Kavitha Ganesan,Yacob Habboush,Senan Sultan

DOI: https://doi.org/10.7759/cureus.2947

2018-07-09

Cureus

Abstract:Obesity is a worldwide epidemic due to the availability of many unhealthy food options and limited physical exercise. Restriction of the daily food intake results in weight loss, which is also associated with better health outcomes including triglycerides, total cholesterol, low-density lipoprotein cholesterol, blood pressure, glucose, insulin, and C-reactive protein. Our aim is to briefly discuss the effects of intermittent fasting on weight and other biochemical markers mentioned previously. The study is designed as a systematic review according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) checklist. To assess the effectiveness of intermittent fasting, related studies were reviewed between 2000 and 2018 and 815 studies were identified. Only four articles met the preset inclusion and exclusion criteria. All four studies have shown a significant decrease in fat mass with P-values <0.01. It was also noted that some biochemical markers were significantly reduced such as the reduction in low-density lipoprotein and triglyceride with P-values < 0.05. Other biochemical markers had inconsistent results. Based on the qualitative analysis, intermittent fasting was found to be efficient in reducing weight, irrespective of the body mass index. Further studies are needed to assess the ability to maintain the lost weight without regaining it and the long-term effects of such dietary changes.
Intermittent Fasting: A Heart Healthy Dietary Pattern?

Tiffany A. Dong,Pratik B. Sandesara,Devinder S. Dhindsa,Anurag Mehta,Laura C. Arneson,Allen L. Dollar,Pam R. Taub,Laurence S. Sperling

DOI: https://doi.org/10.1016/j.amjmed.2020.03.030

IF: 5.928

2020-08-01

The American Journal of Medicine

Abstract:<p>Dietary patterns, such as the Dietary Approaches to Stop Hypertension and the Mediterranean diet, have been shown to improve cardiac health. Intermittent fasting is another type of popular dietary pattern that is based upon timed periods of fasting. Two different regimens are Alternative Day Fasting and Time-Restricted Eating. Although there are no large, randomized control trials examining the relationship between intermittent fasting and cardiovascular outcomes, current human studies that suggest this diet could reduce the risk for cardiovascular disease with improvement in weight control, hypertension, dyslipidemia and diabetes. Intermittent fasting may exert its effects through multiple pathways including reducing oxidative stress, optimization of circadian rhythms and ketogenesis. This review evaluates current literature regarding the potential cardiovascular benefits of intermittent fasting and proposes directions for future research.</p>
Intermittent fasting for weight management and metabolic health: An updated comprehensive umbrella review of health outcomes

Zixin Hua,Siyu Yang,Jiqian Li,Yiqi Sun,Yin Liao,Siyang Song,Sheng Cheng,Zhe Li,Ze Li,Dandan Li,Heng Guo,Hongge Yang,Yingming Zheng,Xingang Li

DOI: https://doi.org/10.1111/dom.16092

2024-12-02

Diabetes Obesity and Metabolism

Abstract:Aims To provide an updated comprehensive evaluation of the quality and evidence association of existing studies on health outcomes related to intermittent fasting (IF). Materials and Methods We conducted a systematic search of PubMed, Web of Science, Cochrane Library, and Embase databases, covering literature up to June 2024. Meta‐analyses and systematic reviews that include adult populations and quantitatively analyse health outcomes related to IF interventional studies are included. For evidence with complete data, we reanalyzed health evidence effect sizes and 95% confidence intervals using random‐effects models. Article quality and the certainty of the evidence were graded using A Measurement Tool to Assess Systematic Reviews (AMSTAR‐2), Grading of Recommendations Assessment, Development and Evaluation (GRADE) system, and a standardized credibility grading system. Results Twelve meta‐analysis studies and 122 health outcome associations with IF were identified. High‐quality evidence indicated significant associations between time‐restricted eating (TRE) and weight loss, fat mass reduction, decreased fasting insulin and glycosylated haemoglobin levels in overweight or obese adults, as well as between the 5:2 diet and reduced low‐density lipoprotein cholesterol levels. Moderate‐to‐low‐quality evidence suggested associations between modified alternate‐day fasting and improvements in body weight, lipid profile and blood pressure. Additionally, high‐to‐low‐quality evidence showed that IF regimens effectively improved liver health in non‐alcoholic fatty liver disease. Conclusions This umbrella review highlights IF, especially TRE, as a promising intervention for weight and metabolic health, particularly beneficial for overweight or obese adults. We also highlight the need for further extensive research to understand the long‐term effects, individualized IF plans and potential adverse effects of IF in different populations.

endocrinology & metabolism
Intermittent fasting for health care, a review

Valentina Espinoza,Carolina Alarcón,Yaroleth Contreras,Fabiana Sepúlveda,Emilia Bustos,Angelica Palisi,Sharon Viscardi

DOI: https://doi.org/10.37527/2023.73.1.006

2023-03-05

Archivos Latinoamericanos de Nutrición

Abstract:The incidence of obesity and overweight in the world has been increasing in recent years due to poor diet and lack of physical activity; people suffering obesity and overweight, related with malnutrition due to excess, often resort to calorie restriction diets that are usually not very effective. In this context, intermittent fasting (IF) has become popular due to the possibilities for weight loss that it offers. This diet consists of alternating periods of fasting with unrestricted eating; however, its effectiveness and consequences are unknown to most users. This narrative review analyzes whether intermittent fasting contributes to the improvement of body and metabolic composition. The purpose of the review was to examine the available data on the contribution of intermittent fasting to the improvement of body and metabolic composition, in order to provide information and to define the parameters that condition safe achievement of its benefits. IF dieting triggers adaptive cell responses that cause a decrease in lipid oxidative stress markers in individuals with obesity and prediabetes. Metabolic alterations have been found to go hand in hand with the alteration of circadian rhythms; if IF contributes to this effect, it may assist in treating and preventing obesity and associated diseases. However, there are also disadvantages, such as the loss of lean muscle mass by wasting, and increased hypoglycemia.
Intermittent Fasting: Exploring Approaches, Benefits, and Implications for Health and Weight Management

Kathleen Nye,Craig Cherrin,Jan Meires

DOI: https://doi.org/10.1016/j.nurpra.2023.104893

IF: 0.826

2024-02-01

The Journal for Nurse Practitioners

Abstract:Intermittent fasting is an eating pattern that restricts food intake for specific periods. Studies have shown that intermittent fasting can be an effective method for weight loss because it reduces overall calorie intake and increases metabolism. However, consulting a health care professional before starting any new diet or exercise regimen is recommended. This article presents an overview of intermittent fasting, its pathophysiology, associated health benefits, and adverse effects, and provides a guide for the provider in prescribing it.

nursing
The Role of Intermittent Fasting in the Management of Nonalcoholic Fatty Liver Disease: A Narrative Review

Celeste M. Lavallee,Andreina Bruno,Christopher Ma,Maitreyi Raman

DOI: https://doi.org/10.3390/nu14214655

IF: 5.9

2022-11-04

Nutrients

Abstract:Intermittent fasting is a non-pharmacological dietary approach to management of obesity and metabolic syndrome, involving periodic intervals of complete or near-complete abstinence from food and energy-containing fluids. This dietary strategy has recently gained significant popularity in mainstream culture and has been shown to induce weight loss in humans, reduce gut and systemic inflammation, and improve gut microbial diversity and dysbiosis (largely in animal models). It has been hypothesized that intermittent fasting could be beneficial in the management of nonalcoholic fatty liver disease, given the condition's association with obesity. This review summarizes protocols, potential mechanisms of action, and evidence for intermittent fasting in nonalcoholic fatty liver disease. It also highlights practical considerations for implementing intermittent fasting in clinical practice. A search of the literature for English-language articles related to intermittent fasting or time-restricted feeding and liver disease was completed in PubMed and Google Scholar. Potential mechanisms of action for effects of intermittent fasting included modulation of circadian rhythm, adipose tissue and adipokines, gut microbiome, and autophagy. Preclinical, epidemiological, and clinical trial data suggested clinical benefits of intermittent fasting on metabolic and inflammatory markers in humans. However, there was a paucity of evidence of its effects in patients with nonalcoholic fatty liver disease. More clinical studies are needed to determine mechanisms of action and to evaluate safety and efficacy of intermittent fasting in this population.

nutrition & dietetics
Intermittent Fasting and Metabolic Health

Izzah Vasim,Chaudry N. Majeed,Mark D. DeBoer

DOI: https://doi.org/10.3390/nu14030631

IF: 5.9

2022-01-31

Nutrients

Abstract:Given the ongoing strain that the obesity epidemic has placed on public health outcomes, new and effective approaches to weight control are needed. One approach to improving weight and metabolic outcomes is intermittent fasting, which consists of multiple different timing schedules for temporary food avoidance, including alternate-day fasting, other similar full-day fasting patterns, and time-restricted feeding (where the day’s food is consumed over a 6-h period, allowing for 18 h of fasting). These feeding schedules have favorable metabolic effects by intermittently inducing the metabolism of fatty acids to ketones. The regimens overall lead to a decrease in weight and have been linked to improvements in dyslipidemia and blood pressure. While more research is needed on longer-term outcomes and this approach should be avoided in particular health conditions, intermittent fasting should be considered as an option for individuals who have a pattern of unhealthy weight gain using standard eating patterns.

nutrition & dietetics
Intermittent Fasting and Its Effects on Weight, Glycemia, Lipids, and Blood Pressure: A Narrative Review

Elie Naous,Angela Achkar,Joanna Mitri

DOI: https://doi.org/10.3390/nu15163661

IF: 5.9

2023-08-22

Nutrients

Abstract:Metabolic syndrome (MetS) has become a significant public health concern globally. Weight managementis crucial in controlling MetS risk factors, making energy balance and weight loss strategies important in nutrition recommendations. Intermittent fasting (IF) has gained traction as a dietary approach for weight management and cardiovascular risk reduction. However, the effects of IF on cardiovascular risk factors have been inconsistent in previous studies. This review aims to summarize the effects of various types of IF on body mass index (BMI), glycemia, lipid profile, and blood pressure, while providing insights into their clinical implications. A comprehensive search of interventional studies and meta-analyses was conducted, and the results were analyzed. The findings indicate that different types of IF lead to mixed effects. Time-restricted eating (TRE) and alternate-day fasting (ADF) consistently showed decreases in BMI, while the outcomes of intermittent energy restriction (IER) were more uncertain. The effects of IF on glycemia and lipid profile were also variable, with TRE and ADF generally showing positive results. However, the impact of IER remained inconsistent. More research is needed to understand the long-term effects and optimal implementation of IF for managing metabolic syndrome and cardiovascular risk factors.

nutrition & dietetics
Intermittent fasting as a dietary intervention with potential sexually dimorphic health benefits

Julia Rius-Bonet,Salvador Macip,Daniel Closa,Marta Massip-Salcedo

DOI: https://doi.org/10.1093/nutrit/nuae062

2024-06-01

Nutrition Reviews

Abstract:Intermittent fasting (IF) has proven to be a feasible dietary intervention for the wider population. The recent increase in IF clinical trials highlights its potential effects on health, including changes in body composition, cardiometabolic status, and aging. Although IF may have clinical applications in different populations, studies suggest there may be sex-specific responses in parameters such as body composition or glucose and lipid metabolism. Here, the existing literature on IF clinical trials is summarized, the application of IF in both disease prevention and management is discussed, and potential disparities in response to this type of diet between men and women are assessed. Moreover, the potential mechanisms that may be contributing to the sexually dimorphic response, such as age, body composition, tissue distribution, or sex hormones are investigated. This review underscores the need to further study these sex-specific responses to IF to define the most effective time frames and length of fasting periods for men and women. Tailoring IF to specific populations with a personalized approach may help achieve its full potential as a lifestyle intervention with clinical benefits.

nutrition & dietetics
Clinical application of intermittent fasting for weight loss: progress and future directions

Krista A. Varady,Sofia Cienfuegos,Mark Ezpeleta,Kelsey Gabel

DOI: https://doi.org/10.1038/s41574-022-00638-x

2022-02-22

Nature Reviews Endocrinology

Abstract:Nature Reviews Endocrinology, Published online: 22 February 2022; doi:10.1038/s41574-022-00638-xIntermittent fasting diets are increasingly popular alternatives to traditional weight loss methods; however, their efficacy and safety are currently unclear. This Review evaluates the current research on intermittent fasting and discusses the benefits and challenges of these diets.

endocrinology & metabolism
A Pesco-Mediterranean Diet With Intermittent Fasting: JACC Review Topic of the Week

James H O'Keefe,Noel Torres-Acosta,Evan L O'Keefe,Ibrahim M Saeed,Carl J Lavie,Sarah E Smith,Emilio Ros

DOI: https://doi.org/10.1016/j.jacc.2020.07.049

2020-09-22

Abstract:As opportunistic omnivores, humans are evolutionarily adapted to obtain calories and nutrients from both plant and animal food sources. Today, many people overconsume animal products, often-processed meats high in saturated fats and chemical additives. Alternatively, strict veganism can cause nutritional deficiencies and predispose to osteopenia, sarcopenia, and anemia. A logical compromise is a plant-rich diet with fish/seafood as principal sources of animal food. This paper reviews cumulative evidence regarding diet and health, incorporating data from landmark clinical trials of the Mediterranean diet and recommendations from recent authoritative guidelines, to support the hypothesis that a Pesco-Mediterranean diet is ideal for optimizing cardiovascular health. The foundation of this diet is vegetables, fruits, nuts, seeds, legumes, whole grains, and extra-virgin olive oil with fish/seafood and fermented dairy products. Beverages of choice are water, coffee, and tea. Time-restricted eating is recommended, whereby intermittent fasting is done for 12 to 16 h each day.
Beneficial effects of intermittent fasting: a narrative review

Dae-Kyu Song,Yong-Woon Kim

DOI: https://doi.org/10.12701/jyms.2022.00010

2022-04-04

Journal of Yeungnam Medical Science

Abstract:Caloric restriction is a popular approach to treat obesity and its associated chronic illnesses but is difficult to maintain for a long time. Intermittent fasting is an alternative and easily applicable dietary intervention for caloric restriction. Moreover, intermittent fasting has beneficial effects equivalent to those of caloric restriction in terms of body weight control, improvements in glucose homeostasis and lipid profiles, and anti-inflammatory effects. In this review, the beneficial effects of intermittent fasting are discussed.
Intermittent Fasting: Myths, Fakes and Truth on this Dietary Regimen Approach

Simone Brogi,Rita Tabanelli,Sara Puca,Vincenzo Calderone

DOI: https://doi.org/10.3390/foods13131960

IF: 5.2

2024-06-21

Foods

Abstract:Intermittent fasting (IF) has been indicated as a valuable alternative to the classical caloric restriction dietary regimen for lowering body weight and preventing obesity-related complications, such as metabolic syndrome and type II diabetes. However, is it effective? In this review article, we analyzed over 50 clinical studies in which IF, conducted by alternate day fasting (ADF) or time-restricted feeding (TRF), was compared with the caloric restriction approach. We evaluated the different roles of IF in treating and preventing human disorders such as metabolic syndrome, type II diabetes, and some types of cancer, as well as the usefulness of IF in reducing body weight and cardiovascular risk factors such as hypertension. Furthermore, we explored the cellular pathways targeted by IF to exert their beneficial effects by activating effector proteins that modulate cell functions and resistance to oxidative stress. In contrast, we investigated concerns regarding human health related to the adoption of IF dietary regimens, highlighting the profound debate surrounding weight loss regimens. We examined and compared several clinical trials to formulate an updated concept regarding IF and its therapeutic potential.

food science & technology
Effects and possible mechanisms of intermittent fasting on health and disease: a narrative review

Zimei Li,Liansu Huang,Yuheng Luo,Bing Yu,Gang Tian

DOI: https://doi.org/10.1093/nutrit/nuad026

2023-03-22

Nutrition Reviews

Abstract:The imbalance between energy intake and expenditure in an environment of continuous food availability can lead to metabolic disturbances in the body and increase the risk of obesity and a range of chronic noncommunicable diseases. Intermittent fasting (IF) is one of the most popular nonpharmacological interventions to combat obesity and chronic noncommunicable diseases. The 3 most widely studied IF regimens are alternate-day fasting, time-restricted feeding, and the 5:2 diet. In rodents, IF helps optimize energy metabolism, prevent obesity, promote brain health, improve immune and reproductive function, and delay aging. In humans, IF's benefits are relevant for the aging global population and for increasing human life expectancy. However, the optimal model of IF remains unclear. In this review, the possible mechanisms of IF are summarized and its possible drawbacks are discussed on the basis of the results of existing research, which provide a new idea for nonpharmaceutical dietary intervention of chronic noncommunicable diseases.

nutrition & dietetics
Intermittent fasting improves hepatic end points in nonalcoholic fatty liver disease: A systematic review and meta-analysis

Marcia Lange,Devika Nadkarni,Lily Martin,Carolyn Newberry,Sonal Kumar,Tatyana Kushner

DOI: https://doi.org/10.1097/hc9.0000000000000212

2023-08-01

Hepatology Communications

Abstract:Background and Aims: Despite NAFLD being the most prevalent liver disease globally, currently there are no FDA-approved treatments, and weight loss through caloric restriction and enhanced physical activity is the recommended treatment strategy. Intermittent fasting (IF) has been proposed as an alternative strategy with additional cardiometabolic benefits. In this systematic review and meta-analysis, we evaluated the anthropometric, biochemical, and hepatic impacts of IF in patients with NAFLD. Methods: MEDLINE, EMBASE, Cochrane Central, and conference abstracts were searched for IF interventions in adults with NAFLD until April 2, 2023. Meta-analysis with a random effects model was used to compare pre-intervention and post-intervention changes in anthropometric, biochemical, and hepatic end points in the IF intervention group with the control group. Publication bias was assessed using Egger’s test. Results: Fourteen studies were included in the systematic review and ten in the meta-analysis (n = 840 participants, 44.64% male). Studies varied in modalities for NAFLD diagnosis, duration of IF (4–52 weeks), and type of IF (5:2 diet, modern alternate-day fasting, time-restricted eating, or religious fasting). Body weight, body mass index, and waist to hip ratio all significantly improved following fasting intervention ( p < 0.05). Adults with NAFLD showed an improvement in serum alanine transaminase, aspartate aminotransferase, hepatic steatosis (controlled attenuation parameter measured by vibration-controlled transient elastography), and hepatic stiffness (measured by vibration-controlled transient elastography) after fasting intervention ( p < 0.05). Conclusions: There is limited, but moderate- to high-quality evidence to suggest that IF can improve hepatic end points and promote weight loss in adults with NAFLD. Larger randomized controlled studies with extended duration are needed to further validate our findings.

gastroenterology & hepatology
Intermittent Fasting: Is the Wait Worth the Weight?

Mary-Catherine Stockman,Dylan Thomas,Jacquelyn Burke,Caroline M. Apovian

DOI: https://doi.org/10.1007/s13679-018-0308-9

2018-04-26

Current Obesity Reports

Abstract:Purpose of ReviewWe review the underlying mechanisms and potential benefits of intermittent fasting (IF) from animal models and recent clinical trials.Recent FindingsNumerous variations of IF exist, and study protocols vary greatly in their interpretations of this weight loss trend. Most human IF studies result in minimal weight loss and marginal improvements in metabolic biomarkers, though outcomes vary. Some animal models have found that IF reduces oxidative stress, improves cognition, and delays aging. Additionally, IF has anti-inflammatory effects, promotes autophagy, and benefits the gut microbiome. The benefit-to-harm ratio varies by model, IF protocol, age at initiation, and duration.SummaryWe provide an integrated perspective on potential benefits of IF as well as key areas for future investigation. In clinical trials, caloric restriction and IF result in similar degrees of weight loss and improvement in insulin sensitivity. Although these data suggest that IF may be a promising weight loss method, IF trials have been of moderate sample size and limited duration. More rigorous research is needed.

endocrinology & metabolism,nutrition & dietetics

Intermittent fasting for the prevention of cardiovascular disease: implications for clinical practice

Intermittent fasting and cardiovascular disease: A scoping review of the evidence

Intermittent Fasting Regulates Metabolic Homeostasis and Improves Cardiovascular Health

Risks and benefits of intermittent fasting for the aging cardiovascular system

Intermittent Fasting: The Choice for a Healthier Lifestyle

Intermittent Fasting: A Heart Healthy Dietary Pattern?

Intermittent fasting for weight management and metabolic health: An updated comprehensive umbrella review of health outcomes

Intermittent fasting for health care, a review

Intermittent Fasting: Exploring Approaches, Benefits, and Implications for Health and Weight Management

The Role of Intermittent Fasting in the Management of Nonalcoholic Fatty Liver Disease: A Narrative Review

Intermittent Fasting and Metabolic Health

Intermittent Fasting and Its Effects on Weight, Glycemia, Lipids, and Blood Pressure: A Narrative Review

Intermittent fasting as a dietary intervention with potential sexually dimorphic health benefits

Clinical application of intermittent fasting for weight loss: progress and future directions

A Pesco-Mediterranean Diet With Intermittent Fasting: JACC Review Topic of the Week

Beneficial effects of intermittent fasting: a narrative review

Intermittent Fasting: Myths, Fakes and Truth on this Dietary Regimen Approach

Effects and possible mechanisms of intermittent fasting on health and disease: a narrative review

Intermittent fasting improves hepatic end points in nonalcoholic fatty liver disease: A systematic review and meta-analysis

Intermittent Fasting: Is the Wait Worth the Weight?